Answers are grounded in this paper and cite their sources.
Spinal cord injury (SCI) triggers caspase-dependent pyroptosis, amplifying neuroinflammation and secondary damage. Electroacupuncture (EA), a clinically validated rehabilitative intervention, mitigates SCI by targeting pyroptosis-specific mechanisms. Mechanistically, EA inhibits NLRP3 inflammasome assembly and reduces ASC speck formation, thereby suppressing caspase-1 activation. This attenuates gasdermin D (GSDMD) cleavage, pore formation, and IL-1β/IL-18 maturation in microglia and macrophages. Furthermore, EA downregulates cytidine monophosphate kinase 2 (CMPK2) and upregulates calcitonin gene-related peptide (CGRP), disrupting pyroptotic signaling. Evidence from rodent models confirms that EA at spinal Jiaji (EX-B2) or Du meridian acupoints modulates microglial activation and NLRP3/GSDMD-N expression, reducing neuronal pyroptosis and improving motor recovery. While EA demonstrates therapeutic promise via pyroptosis regulation, further mechanistic studies are warranted to define its interactions with non-canonical pathways (e.g., caspase-4/5/11). This review synthesizes current evidence and identifies molecular targets for optimizing EA-based neuroprotection post-SCI. • Examines EA's potential in treating SCI by regulating pyroptosis. • Review extensive literature to provide an comprehensive research background. • Assess EA efficacy for SCI recovery by integrating preclinical and clinical data. • Analyze challenges in clinical translation of EA and propose solutions.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: